Clinical cardiologist Michael Farkouh, MD, has been named the associate dean for research and clinical trials and a professor of cardiology at Los Angeles-based Cedars-Sinai, effective March 1. Dr.

The common painkiller ibuprofen may boost heart attack risk by blocking the lifesaving effects of aspirin, a controversial study shows. "The public health impact of this is monstrous," Michael Farkouh ...

An associate clinical professor of medicine at Mount Sinai, Dr. Michael Farkouh is a cardiologist who specializes in treating patients with heart disease and diabetes. This column is the third in a ...

Cedars-Sinai has named Michael Farkouh, MD, associate dean of research and clinical trials, the health system said in a Jan. 18 news release. His appointment is effective March 1. Across the health ...

Michael Farkouh, MD, Director of Clinical Trials and Associate Professor of Medicine, Mount Sinai School of Medicine, says that there are many strategies to both prevent and control diabetes mellitus, ...

For diabetic patients with multivessel coronary artery disease, CABG surgery should be the preferred revascularization over PCI regardless of the SYNTAX score, according to the results of a new study.

Clinical trials are meant to determine the safety and efficacy of promising medical strategies, treatments, or devices and ultimately produce the best data available for healthcare decision-making.

(UPDATED) If there’s an area of cardiology in need of reconciliation, revascularization of left main coronary artery disease would be a worthy candidate given the acrimony of the past few years. Now, ...

An international, clinical research trial has shown that patients with diabetes whose multi-vessel coronary artery disease is treated with bypass surgery live longer and are less likely to suffer ...

SAN FRANCISCO, CA — An analysis of the FREEDOM trial, a study that showed a benefit of coronary artery bypass graft (CABG) surgery over PCI in diabetic patients with multivessel disease, confirmed ...

The common painkiller ibuprofen may boost heart attack risk by blocking the lifesaving effects of aspirin, a new study shows. “The public health impact of this is monstrous," Michael Farkouh, director ...